Instituto de Oftalmología Fundación Conde de Valenciana

institutodeoftalmologia.org

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

44

Active

13

Phase 3

2

Total enrollment

3,355

Pipeline matrix

Showing 7 of 7 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment1
Nepafenac and lubricant1
Silicone-based topical formulation with sunscreen (SPF 50) application1
insulin lispro1
Infliximab 0.1%1
Loteprednol1
Ophthalmic administration of tropicamide/phenylephrine 8 mg/50 mg/mL.1

Next readouts

  • 2025-06-01
  • 2026-02-28
  • 2026-03-02
  • 2026-03-31
  • 2026-09
  • 2028-03

Top conditions

  • Dry Eye4
  • Keratoconus4
  • Pterygium3
  • Conjunctivitis, Allergic2
  • Sjogren Syndrome2
  • Recurrent Pterygium2
  • Pterygium of Both Eyes2
  • Thyroid Eye Disease, TED1

Frequently asked questions about Instituto de Oftalmología Fundación Conde de Valenciana

How many clinical trials does Instituto de Oftalmología Fundación Conde de Valenciana have on ClinicalTrials.gov?
Instituto de Oftalmología Fundación Conde de Valenciana is listed as the lead sponsor on 44 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
How many of Instituto de Oftalmología Fundación Conde de Valenciana's trials are in Phase 3?
2 of Instituto de Oftalmología Fundación Conde de Valenciana's trials are in Phase 3, spread across 7 active drug programs.
What therapeutic areas does Instituto de Oftalmología Fundación Conde de Valenciana focus on?
Instituto de Oftalmología Fundación Conde de Valenciana's most-studied conditions on ClinicalTrials.gov are Dry Eye, Keratoconus, Pterygium, Conjunctivitis, Allergic, Sjogren Syndrome.
When are Instituto de Oftalmología Fundación Conde de Valenciana's next clinical trial readouts?
Instituto de Oftalmología Fundación Conde de Valenciana has 6 upcoming primary-completion readouts tracked here; the soonest is “Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye: A Randomized Clinical Trial”, expected around 2025-06-01.